| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |